19 Nov 2025 | 5 Mins Read
Vivanza's September 2025 net sales rise 1744.89% YoY to Rs 55.36 crore
Flipitmoney
Reported Consolidated quarterly numbers for Vivanza Biosciences are: Net Sales at Rs 55.36 crore in September 2025 up 1744.89% from Rs. 3.00 crore in September 2024.Quarterly Net Profit at Rs. 0.56 crore in September 2025 up 3531.61% from Rs. 0.02 crore in September 2024. EBITDA stands at Rs. 0.61 crore in September 2025 up 454.55% from Rs. 0.11 crore in September 2024.